Immediate Impact
58 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
Works of Raymond Przybysz being referenced
Real-World Burden of Nonalcoholic Steatohepatitis
2020
The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A real-world patient-reported outcomes study
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Raymond Przybysz | 74 | 55 | 106 | 60 | 28 | 367 | |
| F Repetto | 43 | 36 | 77 | 34 | 21 | 394 | |
| Adam Pollard | 30 | 32 | 67 | 46 | 19 | 333 | |
| Louise Benoit | 74 | 64 | 60 | 95 | 37 | 359 | |
| Chun-Yi Lin | 39 | 63 | 10 | 46 | 37 | 362 | |
| Su-Fen Qi | 48 | 25 | 19 | 37 | 20 | 303 | |
| Stylianos Vagios | 120 | 113 | 62 | 113 | 35 | 408 | |
| Changhoon Kim | 74 | 67 | 10 | 12 | 33 | 374 | |
| Liese C.C. Pruitt | 38 | 129 | 32 | 11 | 25 | 349 | |
| Zhenyu Wu | 74 | 62 | 130 | 4 | 44 | 411 | |
| Arvind Bakhru | 52 | 60 | 25 | 48 | 13 | 411 |
All Works
Login with ORCID to disown or claim papers
Loading papers...